India's malaria elimination by 2030 hinges on new vaccines and innovative strategies
India aims to eliminate malaria by 2030, a goal complicated by hidden reservoirs, remote geographies, and parasite resistance. Despite an over 80% reduction in malaria burden between 2015-2023, tribal districts still show high rates. The article highlights the challenge of Plasmodium vivax, which causes relapses, and asymptomatic carriers. It discusses new vaccines like RTS,S (first approved, 2021) and R21/Matrix-M (WHO approved, 2023, with 77% efficacy), and the development of transmission-blocking vaccines (TBVs) like India's AdFalciVax. Innovative approaches include whole-parasite vaccines, engineered antibodies, and gene drives targeting mosquitoes, alongside the need for robust infrastructure and political will.
Key Points
- India's ambitious goal to eliminate malaria by 2030 faces challenges from relapse-prone parasites, asymptomatic carriers, and remote regions.
- Significant progress has been made, with over 80% reduction in malaria burden between 2015 and 2023, but pockets of high incidence persist.
- New malaria vaccines, including RTS,S (approved 2021) and R21/Matrix-M (approved 2023 with 77% efficacy), offer promising tools.
- India is developing its own dual-stage transmission-blocking vaccine, AdFalciVax, through ICMR, showing strong preclinical results.
- Future strategies involve whole-parasite vaccines, engineered antibodies, and gene drives to target mosquitoes, alongside strengthening public health infrastructure and political will.
Exam Facts
- India's malaria elimination target: 2030.
- National Centre for Vector Borne Diseases Control (NCVBDC).
- Plasmodium vivax (relapse-prone) and Plasmodium falciparum.
- First approved malaria vaccine: RTS,S (2021).
- R21/Matrix-M vaccine: Oxford and Serum Institute, WHO approved 2023, up to 77% efficacy.
- AdFalciVax: India's first indigenous dual-stage malaria vaccine, developed by ICMR (announced July 2025).
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.